Browse By: Country ι Category ι Publisher ι Tag
Home  »  GlobalData

GlobalData Market Research Reports

GlobalData is the premier source of actionable insight into the energy and healthcare industries. With the combined expertise of more than 1,000 researchers, market analysts and consultants, we provide high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

Combining precision with innovation, our research and consulting solutions ensure our clients stay at the forefront of their markets by integrating accurate market forecasts and analysis on the latest trends and developments with the unrivalled expertise of our analyst teams. Among other benefits, our informed industry perspectives help clients understand how to generate the maximum return from their key markets, identify opportunities from emerging trends, and devise strategies for growth with confidence. 



Innocoll Technologies Ltd - Product Pipeline Analysis, 2014 Update
SummaryInnocoll Technologies Ltd (Innocoll Technologies) is a biopharmaceutical company. The company develops and markets pharmaceutical products and medical devices for the pharmaceutical and medical markets. Its products include cogenzia, xaracoll, gentamicin surgical implant, procoll, and durieva. Innocoll Technologies approved products include zorprevasurgical haemostat, collacare family, gentamicin surgical implant, collexa, lidocoll, collaguard adhesion barrier, and innocoll dental. The companys products are used in a variety of medical applications such as preventing surgical adhesions in the treatment of post-operative or post-traumatic pain or inflammation and treating deep wounds such as ulcers, burns, and acute trauma injuries. It partners with Baxter, EUSA pharma, Merus labs, c
Published Date: Dec 2014
Published By: GlobalData

Price: $750
Transfusion & Transplantation Technologies - Product Pipeline Analysis, 2014 Update
SummaryTransfusion & Transplantation Technologies (3Ti) is a diagnostic company. The company develops automated technology for the diagnostic testing of blood associated with blood transfusions. Its flagship product aegis blood analyzer and associated consumables is used to perform blood grouping, red cell antibody screening/identification, certain donor/recipient cross-matching tests and the testing for infectious diseases. 3Tis analyzer system comprises automated flow cytometry and fluorescent labeled antibodies integrated into a single blood bank analyzer. The companys product is used in hospital transfusion services, clinical reference labs and blood collections centers. 3Ti is headquartered in Atlanta, Georgia, the US.This report is a source for data, analysis, and actionable intellig
Published Date: Dec 2014
Published By: GlobalData

Price: $750
InBios International, Inc. - Product Pipeline Analysis, 2014 Update
SummaryInBios International, Inc. (InBios International) is a medical diagnostic company. The company develops, manufactures and markets medical diagnostic tests for the detection of infectious diseases. It offers immunochemistry test reagents and clinical chemistry test reagents for the in-vitro diagnostic markets. InBios Internationals products include rapid tests, ELISA kits, rapid immunoassays, veterinary products, monoclonal antibodies, and reagents and controls. The companys reagents and controls include analytic specific reagents, human controls and proficiency panels. Its contract manufacturing services include reagent preparation, packaging and kit assembly, assay development, and computerized label printing. The company markets its products through its brands: Kalazar Detect, Try
Published Date: Dec 2014
Published By: GlobalData

Price: $750
Orion Genomics LLC - Product Pipeline Analysis, 2014 Update
SummaryOrion Genomics LLC (Orion Genomics) is a provider of epigenetic research tools and molecular diagnostic products. Its products include colon cancer risk test, bladder cancer screening and lung cancer screening system, and biomarker. Orion Genomics offers diagnostic test products for breast, lung, ovarian, colorectal and other diseases. The company also provides genomics research and clinical laboratory services to healthcare and agricultural research organizations. The company collaborates with Novartis Molecular Diagnostics, Malaysian Palm Oil Board, Johns Hopkins University School of Medicine Baltimore, University of Glasgow Scotland, ViaLactia Biosciences (NZ) Limited and Mayo Clinic. Orion Genomics is headquartered in Saint Louis, Missouri, the US.This report is a source for dat
Published Date: Dec 2014
Published By: GlobalData

Price: $750
Vitatex Inc. - Product Pipeline Analysis, 2014 Update
SummaryVitatex Inc. (Vitatex) is a biotechnology company. The company research and develops new immunochemistry assays and reagents for the in-vitro diagnostic market. Its research products include Vita-Assays, Vita-Cap, tumor angiogenesis and metastasis monoclonal antibodies. Vitatex's Vita-Cap is a series of blood collection tubes formulated using cell adhesion matrices to capture and preserve circulating cells from blood and tissue fluids. The company's Vita-Assays is a cell culture plate formulated using cell adhesion matrices to capture and preserve rare circulating cells after removal of red blood cells from blood and bone marrow. It also provides technology for rare cell detection, cell adhesion matrix and circulating tumor cells to increase cancer detection sensitivity. Vitatex is
Published Date: Dec 2014
Published By: GlobalData

Price: $750
Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis, 2014 Update
SummaryCalypte Biomedical Corporation (Calypte) is a diagnostic service provider. The company carries out development, manufacturing and marketing of in-vitro testing algorithms for improved diagnosis of HIV infection and other chronic diseases. Its products include rapid tests and traditional EIA diagnostic tests, Aware BED EIA, Aware BED EIA DBS Control Pack, Sampling systems and Aware Messenger. The company provides antigens and recombinant proteins along with proprietary reagents, buffers, and other specialty products for the enhancement of immuno-diagnostic assays. It has manufacturing facilities in the US, Thailand, and China. Calypte is headquartered in Portland, Oregon, the US.This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipel
Published Date: Dec 2014
Published By: GlobalData

Price: $750
Optos plc (OPTS) - Product Pipeline Analysis, 2014 Update
SummaryOptos plc (Optos) is a medical technology company dealing with manufacture and marketing of retinal imaging devices. It offers ultra wide field and high resolution retinal imaging devices for early detection of ophthalmic conditions like retinal detachment, glaucoma, cataracts, retinal holes/retinal tears and age-related macular degeneration. The company offers a wide range of medical devices that support different customer segments and patient levels. The companys ultra-widefield technology in synergy with integrated optical coherence tomography (OCT) provides an unequalled combination of wide-field retinal imaging for the practitioner and patient resulting in more targeted treatment regimes. The company divided its products into three categories, namely, diagnostic, image manageme
Published Date: Dec 2014
Published By: GlobalData

Price: $750
Ascenion GmbH - Product Pipeline Analysis, 2014 Update
SummaryAscenion GmbH (Ascenion) is a life science service company. It provides science and research promotion services. The product line of the company includes therapeutic, diagnostic, medical technology, materials and nutrition products. The company provides services, such as steer and support patenting processes, develops commercialization strategies, steer projects to the marketplace, initiate and negotiate licensing and cooperation agreements with industry, coach start-up founders, manage company equities, monitor contract compliance, and manage patent portfolios. The company is a technology transfer and translational research partner to research institutes and organizations, such as Helmholtz and Leibniz Associations, the Hannover Medical School and associated organizations. It is a
Published Date: Dec 2014
Published By: GlobalData

Price: $750
Medisse BV - Product Pipeline Analysis, 2014 Update
SummaryMedisse BV (Medisse) is a medical device company. The company develops resorbable medical implants for soft tissue applications. Its products include FlexiSurge adhesion barrier, scleral buckle, hernia mesh, staple line reinforcement, and periodontal sheet. Medisse is developing a wide range of resorbable implants, which can be used in a large number of surgical indications. The companys FlexiSurge adhesion barrier is a resorbable implant, which is based on polymer platform. Its products find application in the areas of gynecology, general surgery, dermatology, drug delivery and ophthalmology. Medisse is headquartered in Ede, the Netherlands.This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key
Published Date: Dec 2014
Published By: GlobalData

Price: $750
Taewoong Medical Co.,Ltd. - Product Pipeline Analysis, 2014 Update
SummaryTaewoong Medical Co.,Ltd. (Taewoong Medical) is a medical device company. The company develops and manufactures stents and other medical devices. Its products include gastrointestinal stent, taewoong niti-S tracheobronchial stent and urology stent. Taewoong Medical offers gastrointestinal stents such as taewoong niti-S esophageal stents, taewoong niti-S biliary stents, taewoong niti-S pyloric and duodenal stents, and taewoong niti-S enteral colonic stents. The company partners with GI Supply, Instrumed Surgical and HOLT Medical. It markets its products through a network of distributors in domestic and international healthcare markets. Taewoong Medical is headquartered in Gimpo, Gyeonggi-do, South Korea.This report is a source for data, analysis, and actionable intelligence on the co
Published Date: Dec 2014
Published By: GlobalData

Price: $750
BioMedomics, Inc - Product Pipeline Analysis, 2014 Update
SummaryBioMedomics, Inc. (BioMedomics) is a medical diagnostics company. The company conducts research and develops assays and technologies for use in molecular diagnostics. Its diagnostic platform technologies include time-resolved lateral flow immunoassay platform, nanotube based highly sensitive biosensor platform, and novel universal bacterial capture technology. BioMedomics offer tests for sickle cell disease, acetaminophen, H.I.T, and alpha-thalassemia. The company's rapid drug overdose test is used to test drugs of abuse including morphine, cocaine, PCP, methamphetamine and THC. It markets its assays and technologies to corporate strategic partners. BioMedomics is headquartered in Durham, North Carolina, the US.This report is a source for data, analysis, and actionable intelligence
Published Date: Dec 2014
Published By: GlobalData

Price: $750
ProCelo AS - Product Pipeline Analysis, 2014 Update
SummaryProCelo AS (ProCelo) is a medical device company. The company develops and markets diagnostic assays for detection of bacterial infections. Its ProCt product is a diagnostic kit which is used for detection of chlamydia trachomatis. The company's product, ProCt serves the US and Asian markets as RUO kit. Its pipeline products include other kits for detection of STDs of bacterial origin. ProCelo's RUO portfolio is made up by test for various microbes including Neisseria Gonorrhea, Ureaplasma urealyticum, Mycoplasma pneumonia, Haemophilus influenzae B and others. ProCelo is headquartered in Tromso, Norway.This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its majo
Published Date: Dec 2014
Published By: GlobalData

Price: $750
Wright Medical Group, Inc. (WMGI) - Product Pipeline Analysis, 2014 Update
SummaryWright Medical Group, Inc. (Wright) is an international orthopedic medical device company with focus on extremity and biologic solutions. The company designs, manufactures and markets reconstructive joint devices including extremity implants for the shoulder, elbow, foot, ankle and handfoot and ankle productsand tissue-based and synthetic bone graft substitute materials. The companys manufacturing facility in Arlington is ISO 9001 and ISO 13485 certified. Along with its subsidiaries, the company operates in more than 60 countries of the Americas, Europe, Asia-Pacific and Africa. Wright is headquartered in Arlington, Tennessee, the US.The company focuses on thoughtfully designed innovations, based on extensive consumer insight, to meet the needs of patientsand orthopaedic, trauma, an
Published Date: Dec 2014
Published By: GlobalData

Price: $750
Zoll Medical Corporation - Product Pipeline Analysis, 2014 Update
SummaryZOLL Medical Corporation (Zoll) undertakes the designing, manufacturing and marketing of resuscitation devices and systems used for emergency resuscitation of cardiac arrest victims. It develops technologies and software that help clinicians, emergency medical services (EMS) personnel and lay rescuers advance the practice of resuscitation. The company offers products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management. Its priority markets include the US, Canada, Latin America, the UK, Germany, France, the Netherlands, Australia, and Austria. Zoll is a subsidiary of Asahi Kasei Corporation and is headquartered in Massachusetts, the US.The company focuses on product differentiation. Zoll seeks t
Published Date: Dec 2014
Published By: GlobalData

Price: $750
Biocept, Inc. (BIOC) - Product Pipeline Analysis, 2014 Update
SummaryBiocept, Inc. (Biocept) is a diagnostics service provider. The company provides molecular oncology laboratory services. Its services include prognostic CTC enumeration for various solid tumors, levels of sensitivity to detect CTCs, and molecular testing on CTCs. Biocept offers tests to various types of solid tumor cancers. The company's HER2 OncoCEE-BR test is used for the detection of circulating tumor cells (CTC) in the peripheral blood followed by genetic analysis of HER-2 and amplification by FISH. It provides services to other laboratory testing providers, academic institutions, research organizations, bio-pharmaceutical companies, and clinical trial support. Biocept is headquartered in San Diego, California, the US.This report is a source for data, analysis, and actionable int
Published Date: Dec 2014
Published By: GlobalData

Price: $750
Toshiba Medical Systems Corporation - Product Pipeline Analysis, 2014 Update
sualization solutions, and healthcare IT solutions. The company offers its products through subsidiaries in more than 135 countries in the Americas, Europe, Africa, the Middle-East and Asia-Pacific. TMSC is a subsidiary of Toshiba Corporation and is headquartered in Tochigi-ken, Japan.TMSC focuses on capturing higher share in the diagnostic imaging market through innovative product launches at regular intervals. In line with this strategy, the company recently launched Celesteion PET/CT system, Aquilion ONE/ ViSION Edition and Octave Speeder 1.5 Tesla MRI unit, among others.This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report e
Published Date: Dec 2014
Published By: GlobalData

Price: $750
Advanced Medical Solutions Group plc (AMS) - Product Pipeline Analysis, 2014 Update
SummaryAdvanced Medical Solutions Group plc (AMS) is a medical technology company. It designs, manufactures and commercializes wound care dressings and products used for closing wounds and sealing tissues. The companys array of advanced woundcarewound closure and sealantsurgical sutures and collagen products are supplied through major woundcare partners and private label distributors across the world. It uses various medical adhesive technologies to manufacture its products. The company operates in the UK, Germany, the Netherlands, the US, Czech Republic and Russia. AMS is headquartered in Cheshire, the UK.The company continues to view acquisitions as a key part of its growth strategy. These acquisitions are intended to supplement its core growth and offer new opportunities. In line with t
Published Date: Dec 2014
Published By: GlobalData

Price: $750
Exploit Technologies Pte Ltd - Product Pipeline Analysis, 2014 Update
SummaryExploit Technologies Pte Ltd (Exploit Technologies) is a technology transfer company. It provides technologies for license in various sectors industries such as Electronics, energy, Environment, food, life sciences, medical devices, diagnostics, pharmaceuticals and others. The company offers services related to licensing, startups and collaborate. Its key services include investment services, spinoff services others. Exploit Technologies also offers IP management and intellectual property services. The company has partnership with research institutes, namely, Bioprocessing Technology Institute, Institute of Bioengineering and Nanotechnology, and Singapore Institute for Clinical Sciences among othersand government agencies such as Singapore workforce development agency, Media Develop
Published Date: Dec 2014
Published By: GlobalData

Price: $750
Biohit Oyj (BIOBV) - Product Pipeline Analysis, 2014 Update
SummaryBiohit Oyj (Biohit) is a biotechnology company. The company develops manufactures and markets diagnostic tests and analysis system. Its products include acetaldehyde binding products, diagnostic tests, monoclonal antibodies, instruments and pipettes. Biohit develops and manufactures monoclonal antibodies for research use and use as raw materials for diagnostic industry. The company also provides laboratory equipment, such as microplate instruments and automates, as well as liquid handling products to support Biohit ELISA tests. It offers tests for the diagnosis of lactose intolerance and Helicobacter pylori infection in connection with gastroscopy, and the ColonView examination for the early detection of fecal occult intestinal bleeding. Biohit is headquartered in Helsinki, Finland.
Published Date: Dec 2014
Published By: GlobalData

Price: $750
Occlutech International AB - Product Pipeline Analysis, 2014 Update
SummaryOcclutech International AB (Occlutech) develops and manufactures heart implant products. Its product portfolio encompasses Occlutech figulla flex II, Sizing Occlutech ASD, Occlutech PDA Occluder, Figulla Flex UNI, Occlutech Delivery Set, and stiff guidewire, among others. The company develops Stiff guide wire using a stainless steel core with a PTFE coating. Occlutechs patented technology platform uses nanotechnologies for coating and covering of implants. It markets products under brand name, Occlutech. The companys products are used in the treatment of patent ductus arteriosus, arterial septal defects, the left atrial appendage, and other indications. It has research and development and production facilities in Germany, Turkey, and Sweden. The company markets products in Germany,
Published Date: Dec 2014
Published By: GlobalData

Price: $750
RTI Surgical, Inc. (RTIX) - Product Pipeline Analysis, 2014 Update
SummaryRTI Surgical, Inc. (RTI), formerly RTI Biologics, Inc., is a surgical implant company. The company develops and markets biologic, metal and synthetic implants. Its products include spine implants, sports medicine implants, surgical specialties, osteobiologics and dental implants. RTI offers spine implants such as anterior cervical plate system, vertebral body replacement system, bicortical spacer, tricortical spacer, unicortical spacer, bone graft substitutes, bridge implant, cancellous chips and cubes, dbm pastes and putties, and xenograft cancellous chips and cubes. The companys sports medicine implants include allografts and xenografts.It serves needs of surgeons. The company has manufacturing facilities throughout the US and Europe. RTI is headquartered in Alachua, Florida, the
Published Date: Dec 2014
Published By: GlobalData

Price: $750
Chembio Diagnostics, Inc. (CEMI) - Product Pipeline Analysis, 2014 Update
SummaryChembio Diagnostics, Inc. (Chembio) together with its wholly owned subsidiary Chembio Diagnostic Systems, Inc., undertakes the development, manufacture and marketing of point-of-care diagnostic (POCs) tests that detect infectious diseases. The major commercially available products of the company include four rapid tests for the detection of HIV antibodies, two rapid tests for the detection of syphilis and a rapid test for the detection of canine leishmaniasis. Its new product pipeline is based on Dual Path Platform (DPP) technology. The company offers its products to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals and retailers. It also offers veterinary diagnostics. Chembio is headquartered in Medfor
Published Date: Dec 2014
Published By: GlobalData

Price: $750
Solar PV Balance of System - Global Market Size, Technology Review, Cost Analysis, and Key Country Analysis to 2020
Solar PV Balance of System - Global Market Size, Technology Review, Cost Analysis, and Key Country Analysis to 2020SummarySolar PV Balance of System - Global Market Size, Technology Review, Cost Analysis, and Key Country Analysis to 2020 is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the global solar PV BOS market.The report provides in depth analysis on global solar PV BOS market. The report also provides solar PV BOS market analysis of key countries including the US, Canada, Germany, UK, India, and China. The research provides historical and forecast data to 2020 for installed capacity, overall BOS cost, and BOS marketsize. The report also provides the historic and present costs and market sizes of major h
Published Date: Dec 2014
Published By: GlobalData

Price: $3995
MediPoint: Craniomaxillofacial Devices - US and 5EU Analysis and Market Forecasts
MediPoint: Craniomaxillofacial Devices - US and 5EU Analysis and Market ForecastsSummaryCraniomaxillofacial (CMF) surgery is a highly specialized branch of orthopedic surgery that focuses on all aspects of facial and skull disorders. In this report, GlobalData covers the following segments: CMF plate and screw fixation, CMF distraction, cranial flap fixation, temporomandibular joint (TMJ) replacement, CMF bone graft substitutes, and thoracic fixation (rigid fixation only). Throughout the report, adoption patterns, procedure volumes, and market revenues for all the aforementioned segments are included. In addition, GlobalData included an analysis on the dural repair market, which consists of dural substitutes and dural sealants. However, procedure numbers and market revenues for dural repai
Published Date: Dec 2014
Published By: GlobalData

Price: $6495
Qatar Power Market Outlook to 2030, Update 2014 - Market Trends, Regulations and Competitive Landscape
Qatar Power Market Outlook to 2030, Update 2014 - Market Trends, Regulations and Competitive LandscapeSummaryThis report elaborates Qatars power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of Qatars power markets regulatory structure, import and export trends, competitive landscape and power projects at various stages of the supply chain is provided. The report also gives a snapshot of the power sector in Qatars on broad parameters of macroeconomics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario and future potential.Scope- Snapshot of the countrys power sector across parameters - macro economics, supply security, generation infrastru
Published Date: Dec 2014
Published By: GlobalData

Price: $1500
Algeria Power Market Outlook to 2030, Update 2014 - Market Trends, Regulations, and Competitive Landscape
Algeria Power Market Outlook to 2030, Update 2014 - Market Trends, Regulations, and Competitive LandscapeSummaryThis report elaborates Algerias power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the Algerian power markets regulatory structure, import and export trends, competitive landscape and power projects at various stages of the supply chain is provided. The report also gives a snapshot of the power sector in Algeria on broad parameters of macroeconomics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario and future potential. Financial performance of the leading power companies is also analyzed in the report.Scope- Snapshot of the
Published Date: Dec 2014
Published By: GlobalData

Price: $1500
Malaysia Power Market Outlook to 2030, Update 2014 - Market Trends, Regulations and Competitive Landscape
Malaysia Power Market Outlook to 2030, Update 2014 - Market Trends, Regulations and Competitive LandscapeSummaryThis report elaborates Malaysias power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of Malaysias power markets regulatory structure, import and export trends, competitive landscape and power projects at various stages of the supply chain is provided. The report also gives a snapshot of the power sector in Malaysias on broad parameters of macroeconomics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario and future potential.Scope- Snapshot of the countrys power sector across parameters - macro economics, supply security, generati
Published Date: Dec 2014
Published By: GlobalData

Price: $1500
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - DenmarkSummaryGlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Denmark". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Denmark. It identifies the key trends in the countrys healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by G
Published Date: Dec 2014
Published By: GlobalData

Price: $1995
EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023
EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023SummaryColorectal cancer (CRC) is cancer that starts in the colon or the rectum. CRC has the third highest incidence among all cancers in men and second highest in women. CRC is a high mortality cancer, with mortality rates just behind lung, liver, and stomach cancers in men, and breast and lung cancers in women. Most cases of CRC start as small adenoma polyps in the inner lining of the colon or rectum. CRC screening aims to identify and remove polyps when they are small to prevent the polyps from changing into cancer and has been shown to be effective in reducing the mortality from CRC.GlobalData epidemiologists forecast that the number of total diagnosed incident cases of CRC in the 8MM is expected to grow from 758,062 case
Published Date: Dec 2014
Published By: GlobalData

Price: $3995
EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023
EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023SummaryRheumatoid arthritis (RA) is an autoimmune disease that causes inflammation of the joints. In RA, the bodys immune system attacks the lining of the joints causing an inflammatory response. RA is characterized by joint swelling, pain, and redness, which can cause bone and cartilage erosion, and joint deformity. The disease can lead to premature mortality, disability, and decreased quality of life.GlobalData epidemiologists forecast an increase in the total prevalent cases of RA in the 8MM, from 12,901,398 total prevalent cases in 2013 to 14,896,291 total prevalent cases in 2023, at an Annual Growth Rate (AGR) of 1.55% over the forecast period. GlobalData epidemiologists also forecast an increase in the diagnosed prev
Published Date: Dec 2014
Published By: GlobalData

Price: $3995
EpiCast Report: Acromegaly and Gigantism - Epidemiology Forecast to 2023
EpiCast Report: Acromegaly and Gigantism - Epidemiology Forecast to 2023SummaryAcromegaly and gigantism are rare disorders of the pituitary gland characterized by the hypersecretion of growth hormone (GH). GH excess beginning in adulthood is known as acromegaly, whereas GH excess beginning during childhood is known as gigantism.GlobalData epidemiologists forecast an increase in the diagnosed prevalent cases of acromegaly in the 6MM from 25,354 diagnosed prevalent cases in 2013 to 26,884 diagnosed prevalent cases in 2023, at an Annual Growth Rate (AGR) of 0.60% in the forecast period. Similarly, GlobalData epidemiologists forecast an increase in the diagnosed prevalent cases of gigantism in the 6MM from 591 diagnosed prevalent cases in 2013 to 621 diagnosed prevalent cases in 2023, at an AG
Published Date: Dec 2014
Published By: GlobalData

Price: $3995
Chile Power Market Outlook to 2030, Update 2014 - Market Trends, Regulations and Competitive Landscape
Chile Power Market Outlook to 2030, Update 2014 - Market Trends, Regulations and Competitive LandscapeSummaryThis report elaborates Chiles power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of Chiles power markets regulatory structure, import and export trends, competitive landscape and power projects at various stages of the supply chain is provided. The report also gives a snapshot of the power sector in Chiles on broad parameters of macroeconomics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario and future potential.Scope- Snapshot of the countrys power sector across parameters - macro economics, supply security, generation infrastru
Published Date: Dec 2014
Published By: GlobalData

Price: $1500
Morocco Power Market Outlook to 2030, Update 2014 - Market Trends, Regulations and Competitive Landscape
Morocco Power Market Outlook to 2030, Update 2014 - Market Trends, Regulations and Competitive LandscapeSummaryThis report elaborates Moroccos power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of Moroccos power markets regulatory structure, import and export trends, competitive landscape and power projects at various stages of the supply chain is provided. The report also gives a snapshot of the power sector in Moroccos on broad parameters of macroeconomics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario and future potential.Scope- Snapshot of the countrys power sector across parameters - macro economics, supply security, generation i
Published Date: Dec 2014
Published By: GlobalData

Price: $1500
Croatia Power Market Outlook to 2030, Update 2014 - Market Trends, Regulations, and Competitive Landscape
Croatia Power Market Outlook to 2030, Update 2014 - Market Trends, Regulations, and Competitive LandscapeSummaryThis report elaborates Croatias power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the Croatian power markets regulatory structure, import and export trends, competitive landscape and power projects at various stages of the supply chain is provided. The report also gives a snapshot of the power sector in Croatia on broad parameters of macroeconomics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario and future potential. Financial performance of the leading power companies is also analyzed in the report.Scope- Snapshot of the
Published Date: Dec 2014
Published By: GlobalData

Price: $1500
Greece Power Market Outlook to 2030, Market Trends, Regulations and Competitive Landscape
Greece Power Market Outlook to 2030, Market Trends, Regulations and Competitive LandscapeSummaryThis report elaborates Greeces power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of Greeces power markets regulatory structure, import and export trends, competitive landscape and power projects at various stages of the supply chain is provided. The report also gives a snapshot of the power sector in Greeces on broad parameters of macroeconomics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario and future potential.Scope- Snapshot of the countrys power sector across parameters - macro economics, supply security, generation infrastructure, tra
Published Date: Dec 2014
Published By: GlobalData

Price: $1500
Global Ethylene Outlook - Continuing Global Expansion of Ethylene Capacity through 2020 Led by the US and China
Global Ethylene Outlook - Continuing Global Expansion of Ethylene Capacity through 2020 Led by the US and ChinaSummaryThe global ethylene industry is witnessing a change in the supply scenario in various parts of the world. In North America, ethylene supply is expected to boom in coming years as abundant and inexpensive natural gas liquids (NGLs) feedstock form shale gas is attracting companies to establish their plants in the region. In contrast to North America, ethylene industry in Europe is suffering from high cost of production due to high crude oil prices as most of plants in the region are based on naphtha feedstock. The Middle East and Africa have also seen tremendous growth in ethylene supply. These increases have seen the region surpass overall capacity of North America in 2013.
Published Date: Nov 2014
Published By: GlobalData

Price: $3000
Biopower in Finland, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company Profiles
Biopower in Finland, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company ProfilesSummary"Biopower in Finland, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the Biopower market in Finland.The report provides an in-depth analysis on global renewable power market and global biopower market with forecasts up to 2025. The report analyzes the power market scenario in Finland (includes conventional thermal, hydro and renewable energy sources) and provides future outlook with forecasts up to 2025. The research details renewable power market outlook in the country (includes wind, small hydro a
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Biopower in United States, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company Profiles
Biopower in United States, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company ProfilesSummary"Biopower in United States, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the Biopower market in United States.The report provides an in-depth analysis on global renewable power market and global Biopower market with forecasts up to 2025. The report analyzes the power market scenario in United States (includes conventional thermal, hydro and renewable energy sources) and provides future outlook with forecasts up to 2025. The research details renewable power market outlook in the country (incl
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Wind Power in Chile, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles
Wind Power in Chile, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company ProfilesSummary"Wind Power in Chile, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the Wind market in Chile.The report provides an in-depth analysis on global renewable power market and global Wind market with forecasts up to 2025. The report analyzes the power market scenario in Chile (includes conventional thermal, hydro and renewable energy sources) and provides future outlook with forecasts up to 2025. The research details
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Biopower in Singapore, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company Profiles
Biopower in Singapore, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company ProfilesSummary"Biopower in Singapore, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the biogas power market in Singapore.The report provides an in-depth analysis on global renewable power market and global biopower market with forecasts up to 2025. The report analyzes the power market scenario in Singapore (includes conventional thermal, hydro and renewable energy sources) and provides future outlook with forecasts up to 2025. The research details renewable power market outlook in the country (includes wind, s
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Biopower in Indonesia, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company Profiles
Biopower in Indonesia, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company ProfilesSummary"Biopower in Indonesia, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the biogas power market in Indonesia.The report provides an in-depth analysis on global renewable power market and global biopower market with forecasts up to 2025. The report analyzes the power market scenario in ndonesia (includes conventional thermal, hydro and renewable energy sources) and provides future outlook with forecasts up to 2025. The research details renewable power market outlook in the country (includes wind, sm
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Biopower in Malaysia, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company Profiles
Biopower in Malaysia, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company ProfilesSummary"Biopower in Malaysia, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the biogas power market in Malaysia.The report provides an in-depth analysis on global renewable power market and global biopower market with forecasts up to 2025. The report analyzes the power market scenario in Malaysia (includes conventional thermal, hydro and renewable energy sources) and provides future outlook with forecasts up to 2025. The research details renewable power market outlook in the country (includes wind, small
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Solar PV Power in Malaysia, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company Profiles
Solar PV Power in Malaysia, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company ProfilesSummary"Solar PV Power in Malaysia, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the solar PV market in Malaysia.The report provides an in-depth analysis on global renewable power market and global solar PV market with forecasts up to 2025. The report analyzes the power market scenario in Malaysia (includes conventional thermal, hydro and renewable energy sources) and provides future outlook with forecasts up to 2025. The research details renewable power market outlook in the country (includes win
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Wind Power in Greece, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles
Wind Power in Greece, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company ProfilesSummary"Wind Power in Greece, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the Wind market in Greece.The report provides an in-depth analysis on global renewable power market and global Wind market with forecasts up to 2025. The report analyzes the power market scenario in Greece (includes conventional thermal, hydro and renewable energy sources) and provides future outlook with forecasts up to 2025.
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Hydropower (Large, Small and Pumped Storage) in Russia, Market Outlook to 2025, 2014 Update - Capacity, Generation, Regulations and Company Profiles
Hydropower (Large, Small and Pumped Storage) in Russia, Market Outlook to 2025, 2014 Update - Capacity, Generation, Regulations and Company ProfilesSummary"Hydropower (Large, Small and Pumped Storage) in Russia, Market Outlook to 2025, 2014 Update - Capacity, Generation, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the hydropower market in Russia.The report provides in depth analysis on global renewable power market and global hydropower market with forecasts up to 2025. The report analyzes the power market scenario in Russia (includes conventional thermal, nuclear, large hydro and renewable energy sources) and provides future outlook with forecasts up to 2025. The research
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014
Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014" provides data on the Community-Acquired Bacterial Pneumonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Community-Acquired Bacterial Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Community-Acquired Bacterial Pneumonia.
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Community-Acquired Infections Global Clinical Trials Review, H2, 2014
Community-Acquired Infections Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Community-Acquired Infections Global Clinical Trials Review, H2, 2014" provides data on the Community-Acquired Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Community-Acquired Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Community-Acquired Infections. This report is built using data and informat
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Complicated Intra-Abdominal Infections Global Clinical Trials Review, H2, 2014
Complicated Intra-Abdominal Infections Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Complicated Intra-Abdominal Infections Global Clinical Trials Review, H2, 2014" provides data on the Complicated Intra-Abdominal Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Complicated Intra-Abdominal Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Complicated Intra-Abdominal Infections.
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Gram-Negative Bacterial Infections Global Clinical Trials Review, H2, 2014
Gram-Negative Bacterial Infections Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Gram-Negative Bacterial Infections Global Clinical Trials Review, H2, 2014" provides data on the Gram-Negative Bacterial Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gram-Negative Bacterial Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gram-Negative Bacterial Infections. This report is buil
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2014
Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2014" provides data on the Gram-Positive Bacterial Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gram-Positive Bacterial Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gram-Positive Bacterial Infections. This report is buil
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
H1N1 Infection Global Clinical Trials Review, H2, 2014
H1N1 Infection Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, H1N1 Infection Global Clinical Trials Review, H2, 2014" provides data on the H1N1 Infection clinical trial scenario. This report provides elemental information and data relating to the clinical trials on H1N1 Infection. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating H1N1 Infection. This report is built using data and information sourced from proprietary databases, primary and secondary research and
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H2, 2014
H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H2, 2014" provides data on the H5N1 Infection (Avian Influenza) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on H5N1 Infection (Avian Influenza). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating H5N1 Infection (Avian Influenza). This report is built using da
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2014
Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2014" provides data on the Hand, Foot And Mouth Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hand, Foot And Mouth Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hand, Foot And Mouth Disease. This report is built using data and information s
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Hemorrhagic Fever Global Clinical Trials Review, H2, 2014
Hemorrhagic Fever Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Hemorrhagic Fever Global Clinical Trials Review, H2, 2014" provides data on the Hemorrhagic Fever clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemorrhagic Fever. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hemorrhagic Fever. This report is built using data and information sourced from proprietary databases, primary and secondar
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Apnea Global Clinical Trials Review, H2, 2014
Apnea Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Apnea Global Clinical Trials Review, H2, 2014" provides data on the Apnea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Apnea. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Apnea. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of ind
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Hepatitis D Global Clinical Trials Review, H2, 2014
Hepatitis D Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Hepatitis D Global Clinical Trials Review, H2, 2014" provides data on the Hepatitis D clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis D. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis D. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analys
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Herpes Infections Global Clinical Trials Review, H2, 2014
Herpes Infections Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Herpes Infections Global Clinical Trials Review, H2, 2014" provides data on the Herpes Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Herpes Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Herpes Infections. This report is built using data and information sourced from proprietary databases, primary and secondar
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Histoplasmosis Global Clinical Trials Review, H2, 2014
Histoplasmosis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Histoplasmosis Global Clinical Trials Review, H2, 2014" provides data on the Histoplasmosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Histoplasmosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Histoplasmosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
HIV-1 Infection Global Clinical Trials Review, H2, 2014
HIV-1 Infection Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, HIV-1 Infection Global Clinical Trials Review, H2, 2014" provides data on the HIV-1 Infection clinical trial scenario. This report provides elemental information and data relating to the clinical trials on HIV-1 Infection. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating HIV-1 Infection. This report is built using data and information sourced from proprietary databases, primary and secondary research
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Nuclear Power in Canada, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company Profiles
Nuclear Power in Canada, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company ProfilesSummary"Nuclear Power in Canada, Market Outlook to 2025, Update 2014 - Capacity, Generation, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the nuclear power market in Canada.The report provides in depth analysis on global nuclear power market with forecasts up to 2025. The report analyzes the power market scenario in Canada (includes thermal conventional, nuclear, large hydro, pumped storage and renewables) and provides future outlook with forecasts up to 2025. The research details nuclear power market outlook in the country and provides forecasts up to 2025.
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Thermal Power in Taiwan, Market Outlook to 2025, Update 2014 - Capacity, Generation, Power Plants, Regulations and Company Profiles
Thermal Power in Taiwan, Market Outlook to 2025, Update 2014 - Capacity, Generation, Power Plants, Regulations and Company ProfilesSummary"Thermal Power in Taiwan, Market Outlook to 2025, Update 2014 - Capacity, Generation, Power Plants, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the thermal power market in Taiwan.The report provides in depth analysis on global thermal power market with forecasts up to 2025. The report analyzes the power market scenario in Taiwan (includes thermal conventional, renewables, large hydro and pump storage, nuclear) and provides future outlook with forecasts up to 2025. The research details thermal power market outlook in the country and provi
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Cooper Energy Limited, Company Intelligence Report
Cooper Energy Limited, Company Intelligence ReportSummaryCooper Energy Limited (Cooper Energy) is an independent upstream energy company engaged in the Exploration and Production (E&P) of oil and gas in Australia, Africa and Asia. In Australia, Cooper Energy has interests in the Cooper, Otway and Gippsland basins. In the Cooper Basin, the company has interests in four exploration licenses, 20 retention licenses and 11 production licenses. In the Otway Basin, the company has interests in eight exploration licenses, and, in the Gippsland Basin, it has interests in three production licenses. In Asia, the company conducts E&P activities in three Indonesian tenements: the Sukananti Kerja Sama Operasi (KSO), the Sumbagsel Production Sharing Contract (PSC) and the Merangin III PSC, in the South S
Published Date: Nov 2014
Published By: GlobalData

Price: $1000
Erosive Oral Lichen Planus Global Clinical Trials Review, H2, 2014
Erosive Oral Lichen Planus Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Erosive Oral Lichen Planus Global Clinical Trials Review, H2, 2014" provides data on the Erosive Oral Lichen Planus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Erosive Oral Lichen Planus. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Erosive Oral Lichen Planus. This report is built using data and information sourced fro
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Chlamydia Infections Global Clinical Trials Review, H2, 2014
Chlamydia Infections Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Chlamydia Infections Global Clinical Trials Review, H2, 2014" provides data on the Chlamydia Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chlamydia Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chlamydia Infections. This report is built using data and information sourced from proprietary databases, prima
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
AIDS-Related Complex Global Clinical Trials Review, H2, 2014
AIDS-Related Complex Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, AIDS-Related Complex Global Clinical Trials Review, H2, 2014" provides data on the AIDS-Related Complex clinical trial scenario. This report provides elemental information and data relating to the clinical trials on AIDS-Related Complex. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating AIDS-Related Complex. This report is built using data and information sourced from proprietary databases, prima
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Bordetella Pertussis Infections Global Clinical Trials Review, H2, 2014
Bordetella Pertussis Infections Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Bordetella Pertussis Infections Global Clinical Trials Review, H2, 2014" provides data on the Bordetella Pertussis Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bordetella Pertussis Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bordetella Pertussis Infections. This report is built using data an
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Botulism Global Clinical Trials Review, H2, 2014
Botulism Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Botulism Global Clinical Trials Review, H2, 2014" provides data on the Botulism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Botulism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Botulism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDat
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014
Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014" provides data on the Community Acquired Pneumonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Community Acquired Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Community Acquired Pneumonia. This report is built using data and information s
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Endophthalmitis Global Clinical Trials Review, H2, 2014
Endophthalmitis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Endophthalmitis Global Clinical Trials Review, H2, 2014" provides data on the Endophthalmitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Endophthalmitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Endophthalmitis. This report is built using data and information sourced from proprietary databases, primary and secondary research
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Croup Global Clinical Trials Review, H2, 2014
Croup Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Croup Global Clinical Trials Review, H2, 2014" provides data on the Croup clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Croup. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Croup. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of ind
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Hepatitis C Global Clinical Trials Review, H2, 2014
Hepatitis C Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Hepatitis C Global Clinical Trials Review, H2, 2014" provides data on the Hepatitis C clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis C. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis C. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analys
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Hepatitis B Global Clinical Trials Review, H2, 2014
Hepatitis B Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Hepatitis B Global Clinical Trials Review, H2, 2014" provides data on the Hepatitis B clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis B. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis B. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analys
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Global Clinical Trials Review, H2, 2014
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Global Clinical Trials Review, H2, 2014" provides data on the Clostridium Difficile Infections (Clostridium Difficile Associated Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Clostridium Difficile Infections (Clostridium Difficile Associated Disease). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
MediPoint: Coronary Stents - Current and Future Players
D, and bifurcation lesions. The coronary stents market is largely dominated by a few key players, including Abbott Vascular, Boston Scientific, and Medtronic, followed by Biosensors International and Terumo Corporation.Scope- Investigation of current and future market competition for Coronary Stents.- Competitor assessment including device approval analysis.- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.- Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.- Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Coronary Stents in clinical practice.Reasons to buy- Gain a high level view of the trends shaping and driving the Coronary St
Published Date: Nov 2014
Published By: GlobalData

Price: $3500
MediPoint: Coronary Stents - EU Analysis and Market Forecasts
MediPoint: Coronary Stents - EU Analysis and Market ForecastsSummaryThe global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes.The coronary stents market in the EU has an overall negative CAGR of 0.5% over the forecast period from 2011-2020. Similar to the US, the DES market in the EU has the largest share, where the DES market is four times that of the BMS market. Moving forwa
Published Date: Nov 2014
Published By: GlobalData

Price: $4450
MediPoint: Coronary Stents - US Analysis and Market Forecasts
MediPoint: Coronary Stents - US Analysis and Market ForecastsSummaryThe global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes.Each year, millions of individuals are affected by CAD worldwide. Given the high burden of the disease, it is important to develop innovative technologies that can improve outcomes and disease management. Stenting for coronary applications has been wide
Published Date: Nov 2014
Published By: GlobalData

Price: $4450
MicroPort Scientific Corporation (853) - Product Pipeline Analysis, 2014 Update
SummaryMicroPort Scientific Corporation (MicroPort) is a medical device manufacturer. The company develops, manufactures and markets products to treat vascular diseases and disorders. Its products include cardiovascular intervention products, orthopedic medical devices, diabetes and endocrine medical equipment, medical equipment electrophysiology, aortic and peripheral vascular intervention products, neurological interventional products, and others. MicroPort is headquartered in Shanghai, China.This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strateg
Published Date: Nov 2014
Published By: GlobalData

Price: $750
Vermillion, Inc. (VRML) - Product Pipeline Analysis, 2014 Update
SummaryVermillion, Inc. (Vermillion) is a healthcare service provider. The company develops and commercializes multi-marker, diagnostic tests, which addresses unmet needs in gynecologic oncology and womens health. It manufactures OVA1 product. Vermillion's research and development center develops and validates biomarkers and algorithms. The company collaborates with other academic institutions in oncology, cardiology and womens health. It partners with Johns Hopkins University School of Medicine, University of Kentucky, and Stanford University. The company offers its services to patients in various states in the country. Vermillion is headquartered in Austin, Texas, the US.This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products
Published Date: Nov 2014
Published By: GlobalData

Price: $750
mc10 Inc. - Product Pipeline Analysis, 2014 Update
SummaryMC10, Inc. (MC10) is a medical device company. The company develops and manufactures electronic technology products for use in the medical devices, defense and consumer products sector. Its products include CHECKLIGHT, hydration sensor, heart rate and activity wristband, cosmetics, baby monitoring devices, remote monitoring devices and interventional catheters. MC10's technology platform is a combination of conventional electronics and novel mechanics which enable development and production of thin, conformal electronic systems. The company's CHECKLIGHT product is a head impact indicator used by athletes. MC10 is headquartered in Cambridge, Massachusetts, the US.This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. Th
Published Date: Nov 2014
Published By: GlobalData

Price: $750
Lifetech Scientific (Shenzhen) Co., Ltd. (8122) - Product Pipeline Analysis, 2014 Update
SummaryLifetech Scientific (Shenzhen) Co., Ltd. (Lifetech Shenzhen) is a medical device manufacturer. The company designs, manufactures and sells medical devices for cardiovascular and peripheral vascular diseases and disorders. It offers products such as occluders, steerable introducer, delivery systems, balloon catheter, balloon catheter set, vascular plug system, vena cava filters, stent graft systems and snare systems. Lifetech Shenzhen operates through its subsidiaries, branch and sales offices in Shenzhen, Beijing, Shanghai, Guangzhou, Hong Kong, and India. The company operates as a subsidiary of Lifetech Scientific Corporation. Lifetech Shenzhen is headquartered in Shenzhen, China.This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pi
Published Date: Nov 2014
Published By: GlobalData

Price: $750
Akers Biosciences, Inc. (AKER) - Product Pipeline Analysis, 2014 Update
SummaryAkers Biosciences, Inc. (ABI) is a diagnostic product manufacturer. The company develops proprietary in vitro diagnostic technologies. Its products include BreathScan, CHUBE, METRON, PIFA PLUSS PF4, tri-cholesterol, IFA Chlamydia, PIFA Dengue Fever, PIFA Malaria, PIFA Syphilis, and others. ABI's technologies include testing platform technology, and sample preparation technology. The company's testing platform technologies include MPC biosensor, particle immunofiltration assay, rapid enzymatic assay, minDNA, and synthetic macrocycle complex. ABI is headquartered in New Jersey, the US.This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brand
Published Date: Nov 2014
Published By: GlobalData

Price: $750
Spine Smith, LP - Product Pipeline Analysis, 2014 Update
SummarySpine Smith, LP (SpineSmith) is a medical equipment company. The company designs and produces medical devices for stabilization and treatment. Its products include hardware technologies, regenerative technologies and pre-surgical orthopedic conditioning. SpineSmith s hardware technologies designs and engineers innovative technologies focused on the stabilization and treatment of spinal and orthopedic disorders. The companys regenerative technologies promote the repair and regeneration of tissue through cell based therapies and biological delivery systems. Its presurgical conditioning offers WAVE (Whole-body Advanced Vibration Therapy) technology to advance the healing ability of regenerative cells in spinal procedures. . Spine Smith is headquartered in Austin, Texas, the US.This re
Published Date: Nov 2014
Published By: GlobalData

Price: $750
Substation Automation System 2014 Update - Market Size, Volume and Key Country Analysis to 2020
Substation Automation System 2014 Update - Market Size, Volume and Key Country Analysis to 2020SummaryGlobalData, the industry analysis specialist, has released its latest research, Substation Automation System 2014 Update - Market Size, Volume and Key Country Analysis to 2020, which provides in-depth analysis of the substation automation system market at global and key country level.The report covers CHP installed capacity, annual steam and gas turbine for CHP market size and split by type of plant or technology for all the markets. It discussed the regional CHP capacity and gas turbine and steam turbine market along with drivers and restraints at the regional level for North America and Europe.Scope- The report provides the technology overview, global market drivers and restraints for th
Published Date: Nov 2014
Published By: GlobalData

Price: $3995
Solar PV Power in Greece, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles
Solar PV Power in Greece, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company ProfilesSummary"Solar PV Power in Greece, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the solar PV market in Greece.The report provides an in-depth analysis on global renewable power market and global solar PV market with forecasts up to 2025. The report analyzes the power market scenario in Greece (includes conventional thermal, hydro and renewable energy sources) and provides future outlook with forecasts up to 2025.
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Solar PV Power in Romania, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles
Solar PV Power in Romania, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company ProfilesSummary"Solar PV Power in Romania, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the solar PV market in Romania.The report provides an in-depth analysis on global renewable power market and global solar PV market with forecasts up to 2025. The report analyzes the power market scenario in Romania (includes conventional thermal, hydro and renewable energy sources) and provides future outlook with forecasts up to 20
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Solar PV Power in Netherlands, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles
Solar PV Power in Netherlands, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company ProfilesSummary"Solar PV Power in Netherlands, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the solar PV market in Netherlands.The report provides an in-depth analysis on global renewable power market and global solar PV market with forecasts up to 2025. The report analyzes the power market scenario in Netherlands (includes conventional thermal, hydro and renewable energy sources) and provides future outlook with fo
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Solar PV Power in Thailand, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles
Solar PV Power in Thailand, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company ProfilesSummary"Solar PV Power in Thailand, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the solar PV market in Thailand.The report provides an in-depth analysis on global renewable power market and global solar PV market with forecasts up to 2025. The report analyzes the power market scenario in Thailand (includes conventional thermal, hydro and renewable energy sources) and provides future outlook with forecasts up t
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Solar PV Power in Belgium, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles
Solar PV Power in Belgium, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company ProfilesSummary"Solar PV Power in Belgium, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the solar PV market in Greece.The report provides an in-depth analysis on global renewable power market and global solar PV market with forecasts up to 2025. The report analyzes the power market scenario in Belgium (includes conventional thermal, hydro and renewable energy sources) and provides future outlook with forecasts up to 202
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Solar PV Power in Czech Republic, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles
Solar PV Power in Czech Republic, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company ProfilesSummary"Solar PV Power in Czech Republic, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the solar PV market in Czech Republic.The report provides an in-depth analysis on global renewable power market and global solar PV market with forecasts up to 2025. The report analyzes the power market scenario in Czech Republic (includes conventional thermal, hydro and renewable energy sources) and provides future out
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Solar PV Power in Switzerland, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles
Solar PV Power in Switzerland, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company ProfilesSummary"Solar PV Power in Switzerland, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the solar PV market in Switzerland.The report provides an in-depth analysis on global renewable power market and global solar PV market with forecasts up to 2025. The report analyzes the power market scenario in Switzerland (includes conventional thermal, hydro and renewable energy sources) and provides future outlook with fo
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Solar PV Power in Chile, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles
Solar PV Power in Chile, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company ProfilesSummary"Solar PV Power in Chile, Market Outlook to 2025, Update 2014 - Capacity, Generation, Levelized Cost of Energy, Equipment Market, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the solar PV market in Chile.The report provides an in-depth analysis on global renewable power market and global solar PV market with forecasts up to 2025. The report analyzes the power market scenario in Chile (includes conventional thermal, hydro and renewable energy sources) and provides future outlook with forecasts up to 2025. The
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Sustained Low Oil Prices Threaten the Development of Northwest Europes Frontier Basins
Sustained Low Oil Prices Threaten the Development of Northwest Europes Frontier BasinsSummaryThe partners in the Johan Castberg and Rosebank fields are continuing to delay the announcement of their Final Investment Decision in order to spend more time maturing the design for their fields development concept. This is due to rising development costs, plummeting commodity prices, uncertainty over the resource base, and a lack of nearby commercial discoveries. In combination, these aspects threaten to severely hamper the development of both Norway and the UKs most promising oil and gas provinces: the Barents Sea and the West of Shetland.Scope- The effect of sustained low oil prices on the development of the West of Shetlands and Barents Sea- The importance of the sanctioning of the Rosebank an
Published Date: Nov 2014
Published By: GlobalData

Price: $1000
Norway Power Market Outlook to 2030, Update 2014 - Market Trends, Regulations and Competitive Landscape
Norway Power Market Outlook to 2030, Update 2014 - Market Trends, Regulations and Competitive LandscapeSummaryThis report elaborates Norways power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of Norways power markets regulatory structure, import and export trends, competitive landscape and power projects at various stages of the supply chain is provided. The report also gives a snapshot of the power sector in Norways on broad parameters of macroeconomics, supply security, generation infrastructure, transmission infrastructure, degree of competition, regulatory scenario and future potential.Scope- Snapshot of the countrys power sector across parameters - macro economics, supply security, generation infra
Published Date: Nov 2014
Published By: GlobalData

Price: $1500
MediPoint: Coronary Stents - Global Analysis and Market Forecasts
MediPoint: Coronary Stents - Global Analysis and Market ForecastsSummaryThe global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes.Among the different types of stents, drug-eluting stents (DES) dominate the market and are considered to be the gold standard of treatment for coronary artery disease. The rising prevalence of disease and associated risk factors, especially in the e
Published Date: Nov 2014
Published By: GlobalData

Price: $6495
Offshore Vessels and Cables Market - Market Size, Competitive Landscape and Key Country Analysis to 2020
Offshore Vessels and Cables Market - Market Size, Competitive Landscape and Key Country Analysis to 2020Summary"Offshore Vessels and Cables Market - Market Size, Competitive Landscape and Key Country Analysis to 2020" is the latest report from GlobalData, the industry analysis specialists that offers information and a comprehensive understanding of the wind power industry.The report discusses the global offshore wind power market, including historical and forecast installed capacity, the market shares of offshore wind turbine manufacturers, and information on offshore project developers. The report also discusses major trends and market forces in the offshore wind power industry.The research provides an understanding of the type of vessels required for offshore wind farm development and hi
Published Date: Nov 2014
Published By: GlobalData

Price: $3995
Male Infertility Global Clinical Trials Review, H2, 2014
Male Infertility Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Male Infertility Global Clinical Trials Review, H2, 2014" provides data on the Male Infertility clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Male Infertility. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Male Infertility. This report is built using data and information sourced from proprietary databases, primary and secondary res
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Women Infertility Global Clinical Trials Review, H2, 2014
Women Infertility Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Women Infertility Global Clinical Trials Review, H2, 2014" provides data on the Women Infertility clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Women Infertility. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Women Infertility. This report is built using data and information sourced from proprietary databases, primary and secondar
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
African Trypanosomiasis Global Clinical Trials Review, H2, 2014
African Trypanosomiasis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, African Trypanosomiasis Global Clinical Trials Review, H2, 2014" provides data on the African Trypanosomiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on African Trypanosomiasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating African Trypanosomiasis. This report is built using data and information sourced from proprietary d
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Anthrax Global Clinical Trials Review, H2, 2014
Anthrax Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Anthrax Global Clinical Trials Review, H2, 2014" provides data on the Anthrax clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anthrax. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anthrax. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's t
Published Date: Nov 2014
Published By: GlobalData

Price: $2500
Aspergillosis Global Clinical Trials Review, H2, 2014
Aspergillosis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Aspergillosis Global Clinical Trials Review, H2, 2014" provides data on the Aspergillosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aspergillosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Aspergillosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-ho
Published Date: Nov 2014
Published By: GlobalData

Price: $2500